Komarkcorp Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Komarkcorp Berhad heeft een totaal eigen vermogen van MYR98.8M en een totale schuld van MYR9.3M, wat de schuld-eigenvermogensverhouding op 9.4% brengt. De totale activa en totale passiva bedragen respectievelijk MYR125.0M en MYR26.1M.

Belangrijke informatie

9.4%

Verhouding schuld/eigen vermogen

RM 9.32m

Schuld

Rente dekkingsratio	n/a
Contant	RM 17.17m
Aandelen	RM 98.84m
Totaal verplichtingen	RM 26.13m
Totaal activa	RM 124.97m

Recente financiële gezondheidsupdates

Recent updates

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Jun 09

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Oct 29

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Apr 08

If You Had Bought Komarkcorp Berhad (KLSE:KOMARK) Shares Three Years Ago You'd Have Earned 371% Returns

Dec 24

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MYR40.4M ) KOMARK } overtreffen de korte termijn passiva ( MYR16.6M ).

Langlopende schulden: De kortetermijnactiva KOMARK ( MYR40.4M ) overtreffen de langetermijnschulden ( MYR9.5M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: KOMARK heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van KOMARK is de afgelopen 5 jaar gedaald van 18.8% naar 9.4%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: KOMARK heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: KOMARK heeft minder dan een jaar aan kasmiddelen als de vrije kasstroom blijft dalen met historische percentages van 17.2 % per jaar.

Komarkcorp Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Recent updates

Full year 2024 earnings released: RM0.15 loss per share (vs RM0.031 loss in FY 2023)

Komarkcorp Berhad, Annual General Meeting, Nov 27, 2024

Komarkcorp Berhad, Annual General Meeting, Nov 14, 2024

Komarkcorp Berhad Announces Cessation of Office of Tengku Ezuan Ismara Bin Tengku Nun Ahmad as Independent and Non Executive Chairman of Remuneration Committee

New minor risk - Share price stability

New minor risk - Share price stability

Full year 2024 earnings released: RM3.81 loss per share (vs RM0.03 loss in FY 2023)

Third quarter 2024 earnings released: RM0.007 loss per share (vs RM0.003 profit in 3Q 2023)

New major risk - Financial position

Second quarter 2024 earnings released: RM0.002 loss per share (vs RM0.003 profit in 2Q 2023)

New major risk - Market cap size

Full year 2023 earnings released: RM0.006 loss per share (vs RM0.015 loss in FY 2022)

Komarkcorp Berhad, Annual General Meeting, Sep 21, 2023

New major risk - Shareholder dilution

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Komarkcorp Berhad Appoints Azizah Binti Sulaiman as Independent and Non Executive Member of Remuneration Committee

Full year 2023 earnings released: RM0.008 loss per share (vs RM0.019 loss in FY 2022)

Komarkcorp Berhad Announces Resignation of Encik Ihsan Bin Ismail as Independent and Non Executive Member of Remuneration Committee

High number of new and inexperienced directors

Full year 2022 earnings released: RM0.019 loss per share (vs RM0.034 loss in FY 2021)

Komarkcorp Berhad, Annual General Meeting, Sep 21, 2022

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.034 loss in FY 2021)

High number of new and inexperienced directors

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

High number of new and inexperienced directors

First quarter 2022 earnings released: RM0.008 loss per share (vs RM0.004 loss in 1Q 2021)

Full year 2021 earnings released: RM0.031 loss per share (vs RM0.027 loss in FY 2020)

Komarkcorp Berhad has completed a Follow-on Equity Offering in the amount of MYR 12.932371 million.

Company Secretary has left the company

Independent & Non-Executive Director has left the company

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Third quarter 2021 earnings released: RM0.011 loss per share (vs RM0.01 loss in 3Q 2020)

Komarkcorp Berhad's Subsidiary Komark Mask (M) Sdn Bhd and Robayu Corporation SP. ZO. O Enter into Supply and Purchase Agreement

New 90-day high: RM0.71

Komark Mask (M) Sdn Bhd Receives FDA and CE Certification

New 90-day low: RM0.41

New 90-day low: RM0.41

New 90-day low: RM0.81

New 90-day low: RM0.90

Komarkcorp Berhad Announces the Appointment of Tan Tong Lang as Company Secretary

Komarkcorp Berhad Announces Resignation of Tai Yit Chan as Joint Secretary, Effective from January 01, 2021

Second quarter 2021 earnings released: RM0.011 loss per share

If You Had Bought Komarkcorp Berhad (KLSE:KOMARK) Shares Three Years Ago You'd Have Earned 371% Returns

Komarkcorp Berhad Announces That Its Subsidiary, Komark Mask Signs Distributorship Agreement with LKL Advance Metaltech Sdn Bhd

Komarkcorp Berhad Announces Resignation of Mr. Chong Jiun Shyang as Chief Financial Officer to Pursue Other Interests

New 90-day high: RM1.28

Komarkcorp Berhad Announces Resignation of Roy Ho Yew Kee as Executive Chairman of Remuneration Committee

Komarkcorp Berhad Appoints Ym Tengku Ezuan Ismara Bin Tengku Nun Ahmad as Independent and Non Executive Chairman of Remuneration Committee

Komarkcorp Berhad Announces Redesignation of Koh Chie Jooi from Chief Operating Officer to Group Chief Executive Officer

First quarter earnings released

New 90-day high - RM1.10

Full year earnings released - RM0.048 loss per share

New 90-day high - RM0.89

New 90-day high - RM0.63

An undisclosed buyer acquired 19.9% stake in Komarkcorp Berhad (KLSE:KOMARK) from KOH HONG MUAN @ KOH GAK SIONG

New 90-day high - RM0.49

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven